- Atrial Fibrillation Outcomes Study: ORBIT-AF
- Azimilide Shield 2
- Effect of Paricalcitol on Coagulation Study (EPOC)
- LiveVest Temporary Defibrillator Study
- Medtronic Product Surveillance Registry
- PROMISE Trial
- PROMUS Element Plus US Post-Approval Study
- SonoSite Study
- The DAPT Study
- XIENCE V(R) Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study
Critical Care Medicine Studies
- Advanced Endometrial Cancer Study - GOG-0258
- Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
- Cervical Neoplasia Study - GOG-0207
- Chemotherapy toxicity in elderly women with ovarian, primary peritoneal or fallopian tube cancer - GOG 273
- Groningen international study on sentinal nodes in vulvar cancer (GROINSS-V) II: An Observational Study - GOG 270
- Newly Diagnosed Uterine or Ovarian Cancer Study
- Outback: GOG 274
- Progression-Free Survival LIvES
- REOLYSIN: GOG 186H
- High Risk Neuroblastoma Study
- Low and Standard Risk Wilms Tumor Study
- Newly Diagnosed ALL or T-cell Study
- Newly Diagnosed Higher Risk Wilms Tumors Study
- Newly Diagnosed Standard Risk B-Precursor ALL
- Newly Diagnosed Standard Risk Medulloblastoma Study
- Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia
- Treatment of High Risk Renal Tumors
Psychiatry & Psychology Studies


